Identification of Therapeutic Areas in Need of Drugs for Children
We believe that this important need would benefit most from a thoughtful team approach to ascertain what is really needed in pediatric drug development. The team could include for example, Dr. Murphy’s group, this pediatric subcommittee and representatives from the AAP, NICHD and PhRMA.